The U.S. Chamber of Commerce’s Equality of Opportunity Initiative in partnership with the Chamber’s Discover & Deliver campaign, hosted Equality of Opportunity in Action: Bridging the Racial Gap for COVID-19 Treatments and Vaccines on Tuesday, February 16 at 1:00 PM EST.
Video: The Case for Clinical Trial Diversity (Part 1)
Across the country, Black Americans are dying at 1.6 times the rate of their white neighbors. Given the disproportionate impact in communities of color, the Chamber believes it is imperative new COVID-19 treatments are tested in populations most impacted by the virus.
On January 19th, the Chamber’s Equality of Opportunity initiative and the Discover & Deliver campaign hosted a conversation about the importance of promoting racial diversity in clinical trials. Quita Highsmith, Vice President and Chief Diversity Officer at Genentech, and Nick Kenny, Chief Scientific Officer at Syneos Health, joined a conversation with Rick Wade, Senior Vice President of Strategic Alliances and Outreach, to discuss what the business community can do to support the inclusion of diverse communities in clinical research.
Interested in learning more? Look below for the second half of the discussion on how to overcome barriers to clinical trials participation, and be sure to join us on February 16th for our live event to continue the conversation.